Also from this source

You just read:

Aeonian Pharmaceuticals closes Seed Funding from Apollo Ventures to develop mTORC1 inhibitors

News provided by

Aeonian Pharmaceuticals, Inc.

Dec 11, 2017, 17:00 EST